CELEX: 62019CA0576
Language: en
Date: 2020-10-29 00:00:00
Title: Case C-576/19 P: Judgment of the Court (Ninth Chamber) of 29 October 2020 — Intercept Pharma Ltd, Intercept Pharmaceuticals Inc. v European Medicines Agency (Appeal — Access to documents of the institutions, bodies, offices or agencies of the European Union — Regulation (EC) No 1049/2001 — Second indent of Article 4(2) — Exception relating to the protection of court proceedings — First indent of Article 4(2) — Exception relating to the protection of commercial interests — Documents submitted in the context of a marketing authorisation application for a medicinal product for human use — Decision to grant a third party access to the documents)

14.12.2020   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 433/13
            
         
      Judgment of the Court (Ninth Chamber) of 29 October 2020 — Intercept Pharma Ltd, Intercept Pharmaceuticals Inc. v European Medicines Agency
      (Case C-576/19 P) (1)
      
      (Appeal - Access to documents of the institutions, bodies, offices or agencies of the European Union - Regulation (EC) No 1049/2001 - Second indent of Article 4(2) - Exception relating to the protection of court proceedings - First indent of Article 4(2) - Exception relating to the protection of commercial interests - Documents submitted in the context of a marketing authorisation application for a medicinal product for human use - Decision to grant a third party access to the documents)
      (2020/C 433/14)
      Language of the case: English
      
         Parties
      
      
         Appellants: Intercept Pharma Ltd, Intercept Pharmaceuticals Inc. (represented by: L. Tsang, Solicitor and F. Campbell, Barrister and by J. Mulryne and E. Amos, Solicitors)
      
         Other party to the proceedings: European Medicines Agency (represented by: T. Jabłoński, S. Drosos, R. Pita, S. Marino and H. Kerr, acting as Agents)
      
         Operative part of the judgment
      
      The Court:
      
                  1.
               
               
                  Dismisses the appeal;
               
            
                  2.
               
               
                  Orders Intercept Pharma Ltd and Intercept Pharmaceuticals Inc. to bear their own costs and to pay those incurred by the European Medicines Agency (EMA).
               
            
         (1)  OJ C 432, 23.12.2019.